G. Hanf

1.2k total citations
22 papers, 952 citations indexed

About

G. Hanf is a scholar working on Physiology, Immunology and Allergy and Cellular and Molecular Neuroscience. According to data from OpenAlex, G. Hanf has authored 22 papers receiving a total of 952 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Physiology, 11 papers in Immunology and Allergy and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in G. Hanf's work include Asthma and respiratory diseases (13 papers), Allergic Rhinitis and Sensitization (11 papers) and Nerve injury and regeneration (5 papers). G. Hanf is often cited by papers focused on Asthma and respiratory diseases (13 papers), Allergic Rhinitis and Sensitization (11 papers) and Nerve injury and regeneration (5 papers). G. Hanf collaborates with scholars based in Germany, United States and Switzerland. G. Hanf's co-authors include O. Noga, G. Kunkel, Joachim Seybold, Jörg Kleine‐Tebbe, Norbert Suttorp, Andreas Grützkau, C. Schäper, Andrea C. Klucken, Simone Rosseau and Jeremy D. Wolfe and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, European Respiratory Journal and Allergy.

In The Last Decade

G. Hanf

22 papers receiving 913 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Hanf Germany 15 578 386 297 189 125 22 952
O. Noga Germany 20 801 1.4× 505 1.3× 484 1.6× 216 1.1× 158 1.3× 33 1.3k
P BEDARD Canada 15 189 0.3× 188 0.5× 225 0.8× 162 0.9× 57 0.5× 21 966
Alvin M. Sanico United States 10 441 0.8× 361 0.9× 181 0.6× 106 0.6× 54 0.4× 17 654
Per S. Skov Denmark 8 324 0.6× 297 0.8× 31 0.1× 97 0.5× 207 1.7× 10 1.0k
Sabine Rochlitzer Germany 11 274 0.5× 68 0.2× 109 0.4× 164 0.9× 126 1.0× 16 560
Constantine P. Spanos Greece 10 90 0.2× 43 0.1× 108 0.4× 35 0.2× 147 1.2× 21 580
Akira Inokuchi Japan 15 119 0.2× 36 0.1× 108 0.4× 112 0.6× 103 0.8× 64 838
Kenzo Tsuzuki Japan 17 261 0.5× 118 0.3× 51 0.2× 191 1.0× 49 0.4× 66 957
Min Yin China 17 225 0.4× 71 0.2× 90 0.3× 21 0.1× 53 0.4× 48 685
Antonia Wallrapp United States 6 194 0.3× 25 0.1× 70 0.2× 82 0.4× 217 1.7× 7 621

Countries citing papers authored by G. Hanf

Since Specialization
Citations

This map shows the geographic impact of G. Hanf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Hanf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Hanf more than expected).

Fields of papers citing papers by G. Hanf

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Hanf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Hanf. The network helps show where G. Hanf may publish in the future.

Co-authorship network of co-authors of G. Hanf

This figure shows the co-authorship network connecting the top 25 collaborators of G. Hanf. A scholar is included among the top collaborators of G. Hanf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Hanf. G. Hanf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Kleine‐Tebbe, Jörg, et al.. (2021). Molekulare Allergiediagnostik mit Pollen-Markerallergenen und -Panallergenen: Fünf Muster bei multiplen Testreaktionen auf Pollenextrakte. Allergologie. 44(6). 450–458. 1 indexed citations
3.
Kanniess, Frank, et al.. (2014). Mometasone furoate delivered via the Breezhaler® and Twisthaler® devices in asthma. 44. 915. 4 indexed citations
4.
Noga, O., Matthias Peiser, R. Wanner, et al.. (2007). Differential activation of dendritic cells by nerve growth factor and brain‐derived neurotrophic factor. Clinical & Experimental Allergy. 37(11). 1701–1708. 32 indexed citations
5.
Noga, O., G. Hanf, G. Kunkel, & Jörg Kleine‐Tebbe. (2007). Basophil Histamine Release Decreases during Omalizumab Therapy in Allergic Asthmatics. International Archives of Allergy and Immunology. 146(1). 66–70. 38 indexed citations
6.
Noga, O., Matthias Peiser, Bernd Schmeck, et al.. (2007). Selective induction of nerve growth factor and brain‐derived neurotrophic factor by LPS and allergen in dendritic cells. Clinical & Experimental Allergy. 38(3). 473–479. 16 indexed citations
7.
Joachim, Ricarda, O. Noga, G. Hanf, et al.. (2007). Correlation between immune and neuronal parameters and stress perception in allergic asthmatics. Clinical & Experimental Allergy. 38(2). 283–290. 31 indexed citations
8.
Noga, O., G. Hanf, Andrea C. Klucken, et al.. (2006). Effect of omalizumab treatment on peripheral eosinophil and T-lymphocyte function in patients with allergic asthma. Journal of Allergy and Clinical Immunology. 117(6). 1493–1499. 132 indexed citations
9.
Hanf, G., Jörg Kleine‐Tebbe, Joachim Seybold, et al.. (2006). Omalizumab decreased IgE‐release and induced changes in cellular immunity in patients with allergic asthma. Allergy. 61(9). 1141–1144. 25 indexed citations
10.
Noga, O., G. Hanf, Q. Thai Dinh, et al.. (2005). Regulation of NGF and BDNF by dexamethasone and theophylline in human peripheral eosinophils in allergics and non-allergics. Regulatory Peptides. 132(1-3). 74–79. 17 indexed citations
11.
Hanf, G., et al.. (2004). Omalizumab inhibits allergen challenge-induced nasal response. European Respiratory Journal. 23(3). 414–419. 50 indexed citations
12.
Hanf, G., Ulrich Ohnemus, Ralf Otto-Knapp, et al.. (2004). Monocytes of allergics and non-allergics produce, store and release the neurotrophins NGF, BDNF and NT-3. Regulatory Peptides. 124(1-3). 19–25. 59 indexed citations
14.
Noga, O., G. Hanf, & G. Kunkel. (2003). Immunological and Clinical Changes in Allergic Asthmatics following Treatment with Omalizumab. International Archives of Allergy and Immunology. 131(1). 46–52. 129 indexed citations
15.
Hanf, G., et al.. (2002). Ozone-Induced Release of Neuropeptides from Human Nasal Mucosa Cells. International Archives of Allergy and Immunology. 129(2). 145–151. 9 indexed citations
16.
Buhl, Roland, G. Hanf, M. Solèr, et al.. (2002). The anti-IgE antibody omalizumab improves asthma-related quality of life in patients with allergic asthma. European Respiratory Journal. 20(5). 1088–1094. 124 indexed citations
17.
Noga, O., et al.. (2002). Activation of the specific neurotrophin receptors TrkA, TrkB and TrkC influences the function of eosinophils. Clinical & Experimental Allergy. 32(9). 1348–1354. 70 indexed citations
18.
19.
Hanf, G., et al.. (2000). Substance P induced histamine release from nasal mucosa of subjects with and without allergic rhinitis. Inflammation Research. 49(10). 520–523. 30 indexed citations
20.
Hanf, G., et al.. (1955). [A contribution on the mode of infection of genital actinomycosis in women].. PubMed. 15(4). 366–74. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026